A significant breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial tumor suppressor protein is frequently disabled in many kinds of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research